Cover Image


View/Hide Left Panel

and highlight some key findings and research directions stemming from this integrative research.

For the purposes of this review, we have limited our consideration of biomarkers mainly to DNA and physiological biomarkers collected from blood (e.g., glycosylated hemoglobin, cholesterol), saliva (cortisol) or urine (cortisol and catecholamines); not included are more functional parameters that are also considered to be biomarkers, such as hand grip strength, measures of vision or hearing, and assessments of cognitive or physical functioning. This chapter highlights the types of questions that can be addressed when social and behavioral studies are supplemented with biomarker data, and therefore we also exclude descriptions of biomarker research derived from postmortem studies of brain tissue. It is important to note, however, the value of postmortem biomarkers for elucidating biological pathways and mechanisms, including those linking social and behavioral measures with disease outcomes. This is illustrated by research from, for example, the Nun’s Study (Snowdon, Kemper, Mortimer, Wekstein, and Markesbery, 1996), the Religious Order Study (Wilson, Bienias, and Evans, 2004), and the Memory and Aging Project (Bennett et al., 2005).

Our decision to focus on physiological parameters and genes was driven in large part by a central goal of the current volume, namely, to help inform social scientists about the potential value of incorporating biomarkers into their projects through exposition of prior research in which analyses of such biomarkers or candidate genes have provided insights into processes and mechanisms affecting healthy aging. In that context, the focus taken herein seems warranted, as such biomarkers have generally not been included in social surveys (whereas assessments of functioning have), so that evidence based on physiological biomarkers is much less well known to the social science community.

Much of the information presented in this chapter derives from the studies summarized in Table 5-1. These were selected to represent a sampling of ongoing community or population-based studies on aging that have collected DNA or other biological or physiological biomarkers and that are not reviewed elsewhere in this volume. We have organized the wide range of findings generated from the studies reviewed according to a number of critical thematic areas that emerged during our review. These include biomarkers and aging, genetic and environmental influences on risk factors for cardiovascular disease (CVD), social and psychological factors, behavior genetics, biomarkers of cognitive aging, biomarkers of physical function and aging, indices of cumulative biological risk, and the relationship between biomarkers and genetic pleiotropy.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement